Christopher K. Murray, CHIEF TECHNICAL OPERATIONS at Blueprint Medicines Corp (BPMC), sold 1,242 shares at $93.65 ($116K) on 2024-03-04, disclosed to the SEC on 2024-03-06.
Scheduled sale ($116k) by CHIEF TECHNICAL OPERATIONS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.65 | 621 | $58K | 50.0% |
| 2 | $93.65 | 621 | $58K | 50.0% |
| Total | $93.65 avg | 1,242 | $116K | 100% |
| Filing → |
| BPMC | SELL | 2023-12-11 | $375K | — | Filing → |
| BPMC | SELL | 2023-12-06 | $43K | — | Filing → |
| BPMC | SELL | 2023-10-30 | $34K | — | Filing → |